Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.

This study is a multicenter randomized controlled trial conducted in Korea. A parallel, two-group randomized design will be with thyroid stimulating hormone suppression therapy group(low TSH group; intervention) is different from the wIthout thyroid stimulating hormone (TSH) suppression therapy group(high TSH group; control).

NCT Number	NCT06971965
Lead Sponsor	National Cancer Center, Korea Collaborators: Seoul National University Hospital, Seoul National University Bundang Hospital
Conditions	Thyroid Cancer, Papillary Thyroid Carcinoma
Enrollment	578 participants
Start Date	2025-06-02
Primary Completion	2027-12-31 (estimated)
Study Completion	2032-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-05-14